Location: | London |
---|---|
Salary: | £38,165 to £44,722 per annum |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 15th October 2024 |
---|---|
Closes: | 29th October 2024 |
Job Ref: | 2676 |
About the Role
The post holder’s primary role will be to coordinate and manage the AttackMS trial (Natalizumab for the treatment of people with inflammatory demyelination suggestive of multiple sclerosis, or definite multiple sclerosis, at first presentation) in collaboration with the lead research team based at the Centre for Neuroscience, Surgery & Trauma and the Trial management Group at the PCTU, both based at Queen Mary, University of London. Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS) affecting >120,000 people in the UK. This trial aims to assess if hyper-acute treatment with natalizumab, 300mg i.v., every four weeks, is effective in facilitating remyelination in people with a first manifestation event of demyelination. AttackMS is a multi-centre, randomised control clinical trial of an Investigational Medicinal Product (CTIMP), which will take place within NHS settings.
The post is based at the Whitechapel Campus in London and is a fixed term appointment for 27 months. Due to the requirements of the role, successful candidates should be available to start by the end of September, if not earlier.
About You
This post represents an exciting opportunity for a self-motivated individual to develop their trial management skills in a multi-site trial of an intervention working with a multidisciplinary team. The post-holder will work in the Centre for Evaluation and Methods (CEM), incorporating collaborative units working to deliver outstanding research based on their combined and complementary strengths. Previous research experience in multi-site Clinical Trials of an Investigational Medicinal Product (CTIMPs) involving NHS patients or research participants is essential.
About the School/Department/Institute/Project
The Centre for Evaluation and Methods (CEM) specialises in evaluating the clinical effectiveness, cost-effectiveness and implementation of healthcare innovations, and methodology to support these evaluations. Our multidisciplinary researchers and educators work to improve the health of patients and the public. Our vision is to improve evidence and methods for a healthier, better world. The postholder will contribute to the Pragmatic Clinical Trials Unit (PCTU), one of four clinical trials units within the centre.
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
Benefits
We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum (pro-rata for part-time/fixed term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, campus facilities and flexible working arrangements.
Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.
Type / Role:
Subject Area(s):
Location(s):